Tahvilian, Shahram
Kuban, Joshua D.
Yankelevitz, David F.
Leventon, Daniel
Henschke, Claudia I.
Zhu, Jeffrey
Baden, Lara
Yip, Rowena
Hirsch, Fred R.
Reed, Rebecca
Brown, Ashley
Muldoon, Allison
Trejo, Michael
Katchman, Benjamin A.
Donovan, Michael J.
Pagano, Paul C.
Article History
Received: 7 February 2023
Accepted: 13 April 2023
First Online: 5 June 2023
Declarations
:
: This study was a multi-center prospective study that included patients with lung nodules identified through CT either through a screening program or incidental finding at participating medical centers in the U.S. Ethics review and approval was obtained by each institution before enrollment and written informed consent was obtained from all patients. All methods were carried out in accordance with relevant guidelines and regulations or declarations of Helsinki.The site name, corresponding ethics committee/Institutional Review Board (IRB), and the IRB number for each site participating in the study is shown below.
: Not applicable.
: JDK, DFY, CUH, JZ, RY, FRH, and MJD receive sponsored research funding from LungLife AI. ST, LB, DL, RR, AB, AM, MT, BAK, and PCP are employees of LungLife AI.